| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |